Fingerprint
Dive into the research topics of 'Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer
William N. William, Merrill S. Kies, Frank V. Fossella, Diane D. Liu, Gregory Gladish, Warner H. Tse, J. Jack Lee, Waun K. Hong, Scott M. Lippman, Edward S. Kim
Research output: Contribution to journal › Article › peer-review
19
Scopus
citations